Connection

Swapan Ray to Calpain

This is a "connection" page, showing publications Swapan Ray has written about Calpain.
Connection Strength

4.490
  1. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor. Neurochem Res. 2007 Dec; 32(12):2210-6.
    View in: PubMed
    Score: 0.264
  2. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis. 2007 Apr; 12(4):671-84.
    View in: PubMed
    Score: 0.258
  3. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer. 2006 Dec 01; 119(11):2575-85.
    View in: PubMed
    Score: 0.252
  4. Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia. Curr Med Chem. 2006; 13(28):3425-40.
    View in: PubMed
    Score: 0.236
  5. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res. 2005 Aug 15; 81(4):551-62.
    View in: PubMed
    Score: 0.230
  6. Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. J Chem Neuroanat. 2003 Oct; 26(2):119-24.
    View in: PubMed
    Score: 0.202
  7. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2003 Jun; 2(3):173-89.
    View in: PubMed
    Score: 0.198
  8. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev. 2003 May; 42(2):169-85.
    View in: PubMed
    Score: 0.196
  9. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res. 2002 Jul 15; 69(2):197-206.
    View in: PubMed
    Score: 0.186
  10. Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP. Neurotox Res. 2020 Oct; 38(3):640-649.
    View in: PubMed
    Score: 0.162
  11. Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
    View in: PubMed
    Score: 0.125
  12. Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. J Neurochem. 2016 10; 139(2):270-284.
    View in: PubMed
    Score: 0.124
  13. Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats. J Neurosci Res. 2012 Nov; 90(11):2134-45.
    View in: PubMed
    Score: 0.093
  14. Calpain inhibition attenuates apoptosis of retinal ganglion cells in acute optic neuritis. Invest Ophthalmol Vis Sci. 2011 Jul 01; 52(7):4935-41.
    View in: PubMed
    Score: 0.086
  15. Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation. Exp Neurol. 2010 Oct; 225(2):430-5.
    View in: PubMed
    Score: 0.081
  16. Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells. J Neurochem. 2009 Sep; 110(6):1895-907.
    View in: PubMed
    Score: 0.076
  17. N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells. Brain Res. 2009 May 01; 1268:142-153.
    View in: PubMed
    Score: 0.074
  18. Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Int J Oncol. 2009 Mar; 34(3):757-65.
    View in: PubMed
    Score: 0.074
  19. Involvement of calpain in the process of Jurkat T cell chemotaxis. J Neurosci Res. 2009 Feb 15; 87(3):626-35.
    View in: PubMed
    Score: 0.073
  20. Time-dependent increases in protease activities for neuronal apoptosis in spinal cords of Lewis rats during development of acute experimental autoimmune encephalomyelitis. J Neurosci Res. 2008 Oct; 86(13):2992-3001.
    View in: PubMed
    Score: 0.071
  21. Extranigral neurodegeneration in Parkinson's disease. Ann N Y Acad Sci. 2008 Oct; 1139:331-6.
    View in: PubMed
    Score: 0.071
  22. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res. 2008 Aug 28; 1227:207-15.
    View in: PubMed
    Score: 0.070
  23. Calpain as a potential therapeutic target in Parkinson's disease. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):305-12.
    View in: PubMed
    Score: 0.070
  24. Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):313-20.
    View in: PubMed
    Score: 0.070
  25. Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. Cancer Invest. 2008 May; 26(4):352-8.
    View in: PubMed
    Score: 0.069
  26. Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochem Res. 2009 Jan; 34(1):66-78.
    View in: PubMed
    Score: 0.069
  27. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res. 2008 May; 44(4):348-57.
    View in: PubMed
    Score: 0.068
  28. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol. 2007 Oct; 190(1-2):139-45.
    View in: PubMed
    Score: 0.066
  29. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells. Neurochem Res. 2007 Dec; 32(12):2094-102.
    View in: PubMed
    Score: 0.066
  30. Methylprednisolone and indomethacin inhibit oxidative stress mediated apoptosis in rat C6 glioblastoma cells. Neurochem Res. 2007 Nov; 32(11):1849-56.
    View in: PubMed
    Score: 0.065
  31. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells. Neurosci Lett. 2007 Mar 30; 415(3):242-7.
    View in: PubMed
    Score: 0.064
  32. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J Neurosci Res. 2006 Oct; 84(5):1064-75.
    View in: PubMed
    Score: 0.062
  33. Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann N Y Acad Sci. 2006 Aug; 1074:349-56.
    View in: PubMed
    Score: 0.062
  34. A role for calpain in optic neuritis. Ann N Y Acad Sci. 2005 Aug; 1053:48-54.
    View in: PubMed
    Score: 0.057
  35. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res. 2005 Jul 01; 81(1):53-61.
    View in: PubMed
    Score: 0.057
  36. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer. 2004 Dec 08; 3(1):36.
    View in: PubMed
    Score: 0.055
  37. Higher calpastatin levels correlate with resistance to calpain-mediated proteolysis and neuronal apoptosis in juvenile rats after spinal cord injury. J Neurotrauma. 2004 Sep; 21(9):1240-54.
    View in: PubMed
    Score: 0.054
  38. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Brain Res. 2004 May 01; 1006(2):150-6.
    View in: PubMed
    Score: 0.053
  39. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res. 2003 Jul 01; 73(1):95-104.
    View in: PubMed
    Score: 0.050
  40. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Ann N Y Acad Sci. 2002 Jun; 965:274-80.
    View in: PubMed
    Score: 0.046
  41. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. J Neurochem. 2013 Jan; 124(1):133-46.
    View in: PubMed
    Score: 0.024
  42. Calpeptin attenuated apoptosis and intracellular inflammatory changes in muscle cells. J Neurosci Res. 2011 Apr; 89(4):536-43.
    View in: PubMed
    Score: 0.021
  43. Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death. Neurochem Res. 2011 Sep; 36(9):1587-93.
    View in: PubMed
    Score: 0.021
  44. Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons. Neurochem Res. 2010 Dec; 35(12):2175-83.
    View in: PubMed
    Score: 0.021
  45. Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. J Neurosci Res. 2010 Aug 15; 88(11):2398-408.
    View in: PubMed
    Score: 0.020
  46. Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. J Neurosci Res. 2010 Jun; 88(8):1738-50.
    View in: PubMed
    Score: 0.020
  47. Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels. Brain Res. 2009 Jun 18; 1276:159-70.
    View in: PubMed
    Score: 0.019
  48. Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia. 2005 Apr 15; 50(2):160-7.
    View in: PubMed
    Score: 0.014
  49. 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J Neurosci Res. 2004 Jun 01; 76(5):688-96.
    View in: PubMed
    Score: 0.013
  50. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res. 2003 May 09; 971(2):178-88.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.